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ABSTRACT 
The direct effect of different vanadium compounds upon alka- 
line phosphatase (ALP) activity was investigated~ Vanadate and 
vanadyl inhibited both the soluble and particulate ALP activity from 
UMR.106 cells and front bovine intestinal ALP. We have also shown 
the inhibition of ALP activity in the soluble fraction of osteoblasts by 
peroxo and hydroperoxo vanadium compounds. ALP activity in the 
particulate fraction was not inhibited by these species; nor was the 
bovine intestinal ALP. Using inhibitors of Tyr-phosphatase (PTPases), 
the soluble ALP was partially characterized as a PTPase. The major 
activity in the particulate fraction represents the bone-specific ALP- 
activity. This study demonstrates that different forms of vanadium 
are direct inhibitors of ALP activity. This effect is dependent on the 
enzymatic activity investigated and on the origin of the ALP. 
Index Entries: Vanadium; alkaline phosphatase; tyrosine-phos- 
phatase; osteoblast cells; bone cells; inhibitory effects. 
INTRODUCTION 
Vanadium is a transition metal of group 5 that shows various oxi- 
dation states. It is present in living systems in trace amounts (1). Vana- 
d ium affects different biological processes uch as the inhibition of NaG 
*Author to whom all correspondence and reprint requests hould be addressed. 
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K+-ATPase, glucose oxidation in adypocites, insulin-mimetic a tions, and 
the inhibition of several Tyrosine-phosphatases (PTPases) (2,3). 
Phosphotyrosine accumulation is induced by vanadate inside the 
cultured cells (4). Vanadium +5 may be reduced to vanadyl +4 in the 
presence of NADPH and 02 during cellular metabolism. Addition of 
peroxo- or hydroperoxide vanadium compounds to permeabilized HL- 
60 granulocytes greatly enhances the phosphotyrosine content of the 
cells (4,5). At present, the mechanism by which phosphotyrosine 
increases i unknown. 
Osteoblast cells are involved in bone formation and their differenti- 
ation is modulated by multiple factors such as hormones, growth fac- 
tors, and ions (6). Various peptide factors stimulate the tyrosine-kinases 
associated to the cognate receptors and subsequently they induce tyro- 
sine-phosphorylation of specific cellular proteins. These effects are coun- 
terbalanced by the presence of the PTPases, which in turn deactivate the 
receptors (7). PTPases have been isolated and characterized in several 
systems. They belong to two general families: receptorqike PTPases asso- 
ciated with membranes, and nonreceptor-like PTPases (8,9). 
The aim of this study was to investigate the direct effect of different 
vanadium compounds upon alkaline phosphatase (ALP) activity. We also 
attempted to characterize the enzymes ensitivity to vanadium from rat 
osteoblast cell line UMR.106. 
METHODS 
Materials 
Vanadium (IV) oxide sulfate (vanadyl sulfate) was obtained from 
Merck, sodium o-vanadate, potassium superoxide, superoxide dismu- 
tase, p-nitrophenylphosphate (pNPP), and catalase were obtained from 
Sigma (St. Louis, MO), as well as the bovine intestinal alkaline phos- 
phatase. Tissue culture materials were provided by Corning or Falcon. 
DMEM and trypsin-EDTA were supplied by Gibco (Gaithersburg, MD) 
and FBS by Gen (Argentina). All other chemicals used were of analytical 
grade from Sigma. 
Solut ions 
Fresh stock solutions of vanadyl sulfate and sodium o-vanadate 
were prepared in distilled water at 100 mM concentration. Peroxovana- 
dium and hydroperoxide vanadium compounds were prepared as previ- 
ously reported (4). 
Cell Culture 
Rat osteosarcoma cell line (UMR.106) were grown in Dulbecco's 
Modified Eagle's medium (DMEM) supplemented with 10% fetal bovine 
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serum (FBS) and antibiotics. Cells were passaged by Trypsin-EDTA treat- 
ment  to 150 cm2 flask once a week. After the cells reached confluence, 
the med ium was removed and the monolayer washed with phosphate 
buffered saline (PBS) pH 7.4 and once in 50 mM Hepes/150 mM NaC1 
buffer containing 1 mM EDTA, 15 mM ~3-mercaptoethanol and 1 mM 
phenylethanosulfonyl fluoride (10). 
Preparation of Cellular Fractions 
Cells were scraped in the above buffer and sonicated at 600 psi/15 
s. The homogenate was centrifuged at 2500 rpm/5  min. The supernatant 
was centr i fuged at 45,000 g/90 min at 4~ The supernatant  (soluble 
fraction) was stored at -70~ The pellet was solubil ized in 50 mM 
Hepes/150 mM NaC1/1% Triton-X100 and recentrifuged as before. The 
final supernatant (particulate fraction) was stored at -70~ Aliquots of 
both fractions were used in protein assay by the Bradford method (11). 
Alkaline Phosphatase Activity (ALP) 
The ALP activity from bovine intestinal mucosa was determined as 
described by Crans (12). In brief, p-n i trophenylphosphate (pNPP) was 
used as a substrate in 20 mM Hepes buffer, pH 8.0, in the presence of 20 
mM KC1 and 30 mM MgC12. Incubation was carried out at room tem- 
perature for 10 min and absorbance at 405 nm was measured in order to 
determine the initial rate of the activity. Under these experimental con- 
ditions, the reaction was linear until 30 min. 
The initial rate of ALP activity in the soluble and particulate frac- 
tions of UMR.106 cells was determined by incubation of 100 ~g protein 
in 20 mM Hepes buffer pH 8.0/20 mM KC1/30 mM MgC12 and 5 mM 
pNPP. Absorbance at 405 nm was monitored at 37~ dur ing 5 min. 
Under  these conditions, the reaction proceeded linearly for 30 min. 
The effect of different vanadium compounds and other agents were 
tested in coincubations with the different enzymes. The inhibitory effect 
was determined as a percentage of the basal initial velocity of the ALP 
activity. 
Statistical Analysis 
The results are expressed as mean _+ SEM (n -- number of cases) and 
compared using Student's t-test. 
RESULTS 
Effect on Bovine Intestinal ALP Activity 
The dependence of the rate of the ALP activity from bovine intes- 
tine upon  vanadate and vanadyl was first investigated. This enzyme had 
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already been proved to be sensitive to vanadium by Crans et al. (12) and 
was used in these studies as a model. Figure 1 shows the dose-depen- 
dent effect of these compounds. Both forms of vanadium were effective 
inhibitors of ALP activity. 
Peroxo and hydroperoxo vanad ium compounds were also investi- 
gated as to their ability to inhibit ALP. However, the enzyme was not 
affected at higher concentrations (100 gM) of these vanad ium species 
(Fig. 2). 
Effects on UMR. 106 Cell ALP Act iv i ty  
The effects of vanadate and vanadyl ions on the initial rate of solu- 
ble and particulate ALP activity of UMR.106 osteoblasts i shown in Fig. 
3. As can be seen, inhibition of the soluble enzyme was of a dose- 
response type (Fig. 3A)o The ED50 values show that vanadate seems to 
be a more effective inhibitor than vanadyl. Particulate activity was inhib- 
ited to a lesser extent than that of the soluble form, and it was not of a 
dose-dependent  type. Maximal inhibit ion was obtained at about 5-10 
lJM for both vanadium species (Fig~ 3B). 
Peroxo and hydroperoxo vanadium compounds effectively inhibited 
soluble ALP activity to the same extent as vanadate. Under similar con- 
ditions, particulate ALP activity was not affected by these compounds  
(Fig. 4). 
Partial Characterization of ALP Activity from Osteoblasts 
In order to characterize ALP activity from osteoblasts UMRA06, we 
used a series of compounds  already demonstrated to be specific 
inhibitors of PTPases (8,10). As shown in Table 1, ammonium molibdate 
inhibits soluble and particulate ALP activity. The inhibition was about 
30-40 and 10-20%, respectively. The extent of such effect was similar to 
that of vanadate. Zn sulfate inhibited about 20% of the basal activity of 
the soluble ALP. The particulate-associated ALP activity was not inhib- 
ited but greatly enhanced by Zn2+ (Table 1). 
DISCUSSION 
There has been an increasing interest in the biological role of vana- 
d ium compounds.  Vanadium and its derivatives are capable of interact- 
ing with various enzyme activities (3). Crans et al. have been working 
with vanadate and vanadyl on alkaline phosphatase activity. They have 
found that vanadium interacts with the enzyme, inducing strong inhibi- 
tions. Other vanad ium derivatives, pervanadates,  are also potential  
inhibitors, as it was previously suggested (4). In this study we did con- 
firm the results of Crans on bovine intestinal mucosa ALP and extended 
the investigations on peroxo vanadium species. The experiments were 
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Fig. 1. Effect of vanadate and vanadyl on ALP activ- 
ity from bovine intestinal mucosa. Initial rate was deter- 
mined by incubation of the enzyme at 22~ for 10 min in 
the absence or presence of variable concentrations of the 
inhibitors. Basal activity was 0.769 _+ 0A25 nmol /min /pg  
protein (n = 3). 
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Fig. 2. Effect of different vanad ium species on 
intestinal ALP activity. The initial rate of reaction was 
measured at 22~ for 10 min without  (basal) or with 
100 ~tM vanadium compounds.  The basal activity was 
0.871 _+ 0.094 nmol /min /~tg  protein (n = 3). 
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Fig. 3. Effect of vanadate and vanadyl on soluble (A) 
and particulate (B) ALP activity from UMR.106 cells. The 
basal activities were 0.0262 _+ 0.002 and 0.0618 + 0.002 
nmol/min/~tg protein, respectively (n -- 6). 
carried out to compare intestinal ALP with enzymes from UMR.106 
osteoblasts and to understand the specificity of the different vanadium 
species as well as their roles in the physiology of the bone. 
Vanadate and vanadyl inhibited both soluble and particulate ALP 
activity from UMR.106 cells and bovine intestinal ALP. Vanadate has 
been extensively used as specific Tyr-phosphatase inhibitor in different 
systems (3), but Ser/Thr-phosphatases are not sensitive to these com- 
pounds (13). Vanadium compounds only partially inhibited ALP activity 
in fraction preparations from UMR osteoblasts, uggesting that Ser/Thr 
phosphatases, acting at pH 8.0, are also present. 
It has been suggested that vanadate may be reduced to vanadyl  
inside the cells and the latter species seems to be the actual inhibitor (4). 
However,  in our cell-free preparations, the two forms were shown to 
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Fig. 4. Effect of different vanadium species on sol- 
uble and particulate ALP activity from UMR.106 ceils. 
The concentration of the different compounds was 100 
btM and the basal activities were 0.0273 + 0.001 and 
0.0202 _+ 0.002 nmol/min/btg protein (n = 6) for soluble 
and particulate fractions, respectively. 
directly interact with ALE Furthermore, in the soluble fraction, vanadate 
shows greater inhibition than vanadyl (Fig. 3A). 
Peroxo and hydroperoxo vanadium compounds were shown to be 
more effective inductors of protein phosphory lat ion i cultured cells 
than vanadate (4). Trudel et al suggest but do not prove that the mecha- 
nism may take place through direct inhibition of Tyr-phosphatases. In 
our experiments, we have shown inhibition of ALP activity in the solu- 
ble fraction of osteoblasts by pervanadate forms. ALP activity in the par- 
ticulate fraction was not inhibited by these species, nor was bovine 
intestinal ALP. 
In other systems it has been shown that pervanadates seem to be 
selective for the Tyr-phosphatase investigated (14). Fantus et al. working 
with bovine intestine ALP and rat liver microsomes found greater inhi- 
bition of tyrosine dephosphorylation with pervanadate than with vana- 
date. They have also shown a little inhibition of ALP activity with 10-100 
wV/pervanadate. In our studies, ALP activity in the particulate fraction 
behaves in a different manner, because it is not inhibited at all. 
The assay we used measures total ALP activity, that is Ser/Thr plus 
Tyr-phosphatases. Moreover, the major component in the particulate frac- 
tion is bone ALP, which is a Zn-metalloenzyme previously characterized 
in membranes of osteoblasts (15). ALP in this fraction fullfilled the crite- 
ria of Zn-metal loenzyme b cause it showed great activation by this ion 
(Table 1). Additionally, in preparations without ~3-mercaptoethanol, the 
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Table 1 
Effect of Cations on ALP Activity from UMR.106 Cells a 
Percent basal activity 
Compound Conc., ~tM Soluble Particulate 
- -  - -  100  • 8 100  • 7 
Vanadate  10 78 + 1 86 _+ 3 
50 74 __+ I b 79 • 1 b 
100 66 • lc 91 • 1 
NH4 molybdate  10 78 _+ lb 87 + 2c 
50 73 _+ 20 - -  
100 61 _+ 70 73 • ld 
Zn  su l fa te  10 96 • 4 161 • 24 
50 85 • 7 - -  
100 78 +_ 4O 242 _+ 8e 
aResults are expressed as mean +_ SEM, 
are: 
bp < 0.05 
cp < 0.02 
dp < 0.01 
ep < 0.001. 
n = 3. Differences vs basal 
effect of Zn was partially lost (data not shown), suggesting that the -SH 
groups are important for the role of Zn upon the ALP activity of 
osteoblasts as it has been shown for other Zn-metalloenzymes (17). 
In the soluble fraction, approx 40% of the ALP activity was charac- 
terized as a Tyr-phosphatase. This part of the activity was also inhibited 
by vanadate, vanadyl, and pervanadate to the same extent. The remain- 
ing ALP activity should be associated with Ser/Thr phosphatases. 
In summary, this study demonstrates that different forms of vana- 
dium are direct inhibitors of ALP activity. This effect is dependent on the 
enzymatic activity investigated and on the origin of the ALP and it can 
account for the stimulation of tyrosine phosphorylation i several sys- 
tems. The data presented will serve for future investigation of peroxo 
vanadium compounds in the phosphory lat ion/dephosphory lat ion 
process associated with cell physiology. 
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